PMC:7018936 / 147-880 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7018936","sourcedb":"PMC","sourceid":"7018936","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7018936","text":"Background: Allergic bronchopulmonary mycosis (ABPM) is an underestimated allergic disease due to fungi. Most reported cases are caused by Aspergillus fumigatus (Af) and are referred to as allergic bronchopulmonary aspergillosis (ABPA). The main risk factor of ABPA is a history of lung disease, such as cystic fibrosis, asthma, or chronic obstructive pulmonary disease. The main diagnostic criteria for ABPA rely on the evaluation of humoral IgE and IgG responses to Af extracts, although these cannot discriminate Af sensitization and ABPA. Moreover, fungi other than Af have been incriminated. Flow cytometric evaluation of functional responses of basophils and lymphocytes in the context of allergic diseases is gaining momentum.","tracks":[]}